PandoraGAN
PandoraGAN generates novel antiviral peptide (AVP) sequences using a Generative Adversarial Network (GAN) to produce candidates that recapitulate physico-chemical properties of known highly active AVPs for accelerated antiviral peptide discovery.
Key Features:
- Generative Adversarial Network (GAN) architecture: Uses a GAN to learn sequence and property distributions from known antiviral peptides.
- Manually curated training dataset: Trained on a dataset of 130 highly active peptides curated from AVPdb and relevant literature.
- Physico-chemical property preservation: Generates sequences that exhibit similar physico-chemical properties to the training AVPs.
- Statistical validation: Performs statistical comparisons between generated sequences and the training set using Pearson’s correlation and the Mann-Whitney U-test.
- Implicit property learning: Model architecture is designed to capture and reproduce implicit properties inherent to antiviral peptides.
- Novel sequence generation: Produces candidate peptide sequences that can reveal patterns not present in the original dataset.
Scientific Applications:
- Antiviral peptide candidate generation: Produces novel AVP sequences for downstream experimental evaluation and lead selection.
- Sequence space expansion: Broadens the searchable AVP sequence space to identify potential candidates against diverse viral pathogens.
- Comparative property analysis: Facilitates comparison of physico-chemical properties between generated candidates and known highly active AVPs.
- Computational lead discovery: Supports early-stage computational discovery in antiviral peptide drug development workflows.
Methodology:
Train a Generative Adversarial Network on a manually curated set of 130 highly active peptides sourced from AVPdb and literature; generate novel peptide sequences with the GAN architecture engineered to capture implicit AVP properties; validate generated sequences by statistical comparison to the training dataset using Pearson’s correlation and the Mann-Whitney U-test.
Topics
Details
- License:
- MIT
- Tool Type:
- web application
- Added:
- 3/19/2021
- Last Updated:
- 3/26/2021
Operations
Publications
Surana S, Arora P, Singh D, Sahasrabuddhe D, Valadi J. PandoraGAN: Generating antiviral peptides using Generative Adversarial Network. Unknown Journal. 2021. doi:10.1101/2021.02.15.431193.